Atrophied Anterior Maxillary Ridges
Conditions
Brief summary
Ridge Augmentation in Atrophic Anterior Maxillary Ridges with a Titanium Reinforced Polytetraflouroethelene Membrane and Anorganic Bovine Bone-Derived Mineral in intervention group and Anorganic Bovine Bone-Derived Mineralwith Particulated Autogenous Bone Chips in control group. CBCT will be done before surgery, immediate after surgery and 6 month to compare the bone gain in mm. Bone sample will be collected during exposure after 6 month of surgery by trephine bur to assess the bone quality through histo-morphometric analysis in order to determine the size, shape and orientation of the bony trabeculae, the size and porosity of the bony cortex in addition to the new bone/ bone substitute ratio * 1ry outcome: Amount of bone gain will be measured using linear measurements from CBCT immediate after surgery and after 6 month. * 2ry outcome: a bone sample will be collected and analyzed under histo-morphometric analysis.
Interventions
OTHERGeistlich Bio-Oss® bovine bone alone
Ridge augmentation by titanium reinforced polytetraflouroethelene membrane and anorganic bovine bone derived mineral alone
Sponsors
Cairo University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* • Patients with atrophied anterior maxillary ridge area. * Age: 18 years and older. * Both sexes. * No intraoral soft and hard tissue pathology. * No systemic condition that contraindicate bone augmentation
Exclusion criteria
* • Heavy smokers more than 20 cigarettes per day.(32) * Patients with systemic disease that may affect normal healing. * Psychiatric problems. * Disorders to bone augmentation are related to history of radiation therapy to the head and neck neoplasia. * Pregnant or nursing women. * Patients with uncontrolled diabetes mellitus, rheumatoid arthritis or osteoporosis. * Patient with previous history of radiotherapy.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Amount of bone gain (height and width in mm) | 6 months | will be measured using linear measurements from CBCT |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| a bone sample will be collected and analyzed under histo-morphometric analysis. (no of bone cells in cubic mm) | 6 months | a bone sample will be collected and analyzed under histo-morphometric analysis. |
Countries
Egypt
Contacts
Primary Contactsherif hegazy, bachelor
Outcome results
None listed